RegeneRx Biopharmaceutica Profile

USD 0.0045  2.05%

Exercise of in-the-money or at-the-money derivative position by Joseph McNay of 66667 shares of RegeneRx Biopharmaceutica

RegeneRx Biopharmaceuticals Inc insider trading alert for exercise of common stock warrant (right to buy) by Joseph McNay, the corporate stakeholder, on October 20, 2017. This event was filed by Regenerx Biopharmaceutica with SEC on 2017-10-20. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

RegeneRx Biopharmaceutica Summary

RegeneRx Biopharmaceuticals Inc (RGRX) is traded on OTC Market in USA. It is located in 15245 Shady Grove Road and employs 3 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 26.35 M. RegeneRx Biopharmaceuticals Inc has 109.79 M outstanding shares of which 43 K shares are at this time shorted by private and institutional investors with about 0.15 trading days to cover. REGENERX BIOPHARM currently holds about 191.23 K in cash with (885.44 K) of positive cash flow from operations.
Check RegeneRx Biopharmaceutica Probability Of Bankruptcy

Ownership Allocation (%)

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Williams Jones Associates LlcCommon Shares150 K26 K
Dumont Blake Investment Advisors LlcCommon Shares60.6 K10 K
View RegeneRx Biopharmaceutica Diagnostics

RegeneRx Biopharmaceutica Risk Profiles

Key Fundamentals

RegeneRx Biopharmaceutica Against Markets

Current Ratings

RegeneRx Biopharmaceutica 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 47% 
Equity ratings for RegeneRx Biopharmaceuticals Inc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair, and regeneration. RegeneRx Biopharmaceuticals, Inc. was founded in 1982 and is headquartered in Rockville, Maryland. RegeneRx Biopharmaceutica operates under Drug Manufacturers - Other classification in USA and traded on OTC Market. It employs 3 people. more
NameRegeneRx Biopharmaceuticals Inc
CEO and President and DirectorJ FinkelsteinView All
Analyst Consensus
Macroaxis Advice
InstrumentUSA Stock View All
Business Address15245 Shady Grove Road
ExchangeOTC Market
Contact Number301 208 9191
CurrencyUSD - US Dollar

Current Sentiment - RGRX

RegeneRx Biopharmaceutica Investor Sentiment
Macroaxis portfolio users are evenly split in their perspective on investing in RegeneRx Biopharmaceuticals Inc. What is your perspective on investing in RegeneRx Biopharmaceuticals Inc? Are you bullish or bearish?
50% Bullish
50% Bearish
Skip  Hide


RegeneRx Biopharmaceutica Analyst Recommendations
Target PriceAdvice# of Analysts
2.0Strong Buy1Odds
RegeneRx Biopharmaceuticals Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
RegeneRx Biopharmaceutica Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


RegeneRx Biopharmaceutica Corporate Directors
Don Elsey Independent Director
Joseph McNay Independent Director, MBA
Raymond Elsey Independent Director